- Home
- VRCA vs INO Comparison
VRCA vs INO Comparison
Compare VRCA & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRCA
- INO
- Stock Information
- Founded
- VRCA 2013
- INO 1979
- Country
- VRCA United States
- INO United States
- Employees
- VRCA N/A
- INO N/A
- Industry
- VRCA Biotechnology: Pharmaceutical Preparations
- INO Medical/Dental Instruments
- Sector
- VRCA Health Care
- INO Health Care
- Exchange
- VRCA Nasdaq
- INO Nasdaq
- Market Cap
- VRCA 58.7M
- INO 69.3M
- IPO Year
- VRCA 2018
- INO 1998
- Fundamental
- Price
- VRCA $4.82
- INO $2.31
- Analyst Decision
- VRCA Hold
- INO Buy
- Analyst Count
- VRCA 5
- INO 5
- Target Price
- VRCA $60.00
- INO $8.80
- AVG Volume (30 Days)
- VRCA 36.2K
- INO 2.2M
- Earning Date
- VRCA 11-03-2025
- INO 11-13-2025
- Dividend Yield
- VRCA N/A
- INO N/A
- EPS Growth
- VRCA N/A
- INO N/A
- EPS
- VRCA N/A
- INO N/A
- Revenue
- VRCA $14,704,000.00
- INO $182,337.00
- Revenue This Year
- VRCA $264.34
- INO N/A
- Revenue Next Year
- VRCA $33.95
- INO $15,775.73
- P/E Ratio
- VRCA N/A
- INO N/A
- Revenue Growth
- VRCA 5.72
- INO N/A
- 52 Week Low
- VRCA $3.82
- INO $1.30
- 52 Week High
- VRCA $20.60
- INO $7.00
- Technical
- Relative Strength Index (RSI)
- VRCA 34.96
- INO 51.99
- Support Level
- VRCA $4.87
- INO $2.26
- Resistance Level
- VRCA $5.23
- INO $2.98
- Average True Range (ATR)
- VRCA 0.33
- INO 0.22
- MACD
- VRCA -0.02
- INO -0.05
- Stochastic Oscillator
- VRCA 11.03
- INO 28.95
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.